Статья

The association between D-dimers in COVID-19 patients and mortality remains beset of uncertainties

J. Gris, P. Loubet, C. Roger, E. Cochery-Nouvellon, J. Mauboussin, L. Muller, S. Bouvier, D. Laureillard, S. Barbar, É. Mercier, J. Lefrant, A. Sotto,
2021

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • J. Gris
    Department of Haematology, CHU Nîmes, University Montpellier, Nîmes, France
  • P. Loubet
    Research Laboratory EA 2992, Montpellier University, Nîmes, France
  • C. Roger
    Faculty of Pharmaceutical and Biological Sciences, Montpellier University, Nîmes, France
  • E. Cochery-Nouvellon
    I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation
  • J. Mauboussin
    Department of Infectious and Tropical Diseases, CHU Nîmes, University Montpellier, Nîmes, France
  • L. Muller
    Department of Anaesthesiology, Critical Care and Emergency Medicine, CHU Nîmes, University Montpellier, Nîmes, France
  • S. Bouvier
  • D. Laureillard
  • S. Barbar
  • É. Mercier
  • J. Lefrant
  • A. Sotto
Название журнала
  • Journal of Thrombosis and Haemostasis
Том
  • 18
Выпуск
  • 8
Страницы
  • 2068-2070
Ключевые слова
  • D dimer; fibrin degradation product; fibrin fragment D; lupus anticoagulant; coronavirus disease 2019; disease severity; hospital admission; human; Letter; mortality; mortality rate; priority journal; prognosis; reference value; risk factor; selection bias; Severe acute respiratory syndrome coronavirus 2; survival; thrombosis; uncertainty; Betacoronavirus; Coronavirus infection; pandemic; virus pneumonia; Betacoronavirus; Coronavirus Infections; Fibrin Fibrinogen Degradation Products; Humans; Lupus Coagulation Inhibitor; Pandemics; Pneumonia, Viral
Издатель
  • Blackwell Publishing Ltd
Тип документа
  • Letter
Источник
  • scopus